Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. [electronic resource]
Producer: 20051227Description: 1879-87 p. digitalISSN:- 0002-953X
- Adult
- Age of Onset
- Antipsychotic Agents -- adverse effects
- Basal Ganglia Diseases -- chemically induced
- Benzodiazepines -- adverse effects
- Blood Glucose -- analysis
- Double-Blind Method
- Drug Administration Schedule
- Fasting
- Female
- Humans
- Lipids -- blood
- Male
- Olanzapine
- Piperazines -- adverse effects
- Psychiatric Status Rating Scales
- Quality of Life
- Schizophrenia -- blood
- Schizophrenic Psychology
- Severity of Illness Index
- Thiazoles -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.